Combined lidocaine and salbutamol inhalation for airway anesthesia markedly protects against reflex bronchoconstriction

Citation
H. Groeben et al., Combined lidocaine and salbutamol inhalation for airway anesthesia markedly protects against reflex bronchoconstriction, CHEST, 118(2), 2000, pp. 509-515
Citations number
34
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CHEST
ISSN journal
00123692 → ACNP
Volume
118
Issue
2
Year of publication
2000
Pages
509 - 515
Database
ISI
SICI code
0012-3692(200008)118:2<509:CLASIF>2.0.ZU;2-B
Abstract
Background: Lidocaine inhalation, in subjects with bronchial hyperreactivit y, attenuates evoked bronchoconstriction but also irritates airways. Whethe r salbutamol pretreatment can mitigate airway irritation and whether combin ed treatment offers more protection than treatment with either drug alone i s unknown. Therefore, we evaluated the effects of the inhalation of lidocai ne, salbutamol, lidocaine and salbutamol combined, and placebo on an inhala tional histamine challenge. Methods: Fifteen patients with mild asthma were selected by a screening pro cedure tie, a provocative concentration of a substance [histamine aerosol o f < 18 mg/mL] causing a 20% fall in FEV1 [PC20]). On 4 different days after pretreatment with the inhalation of lidocaine (5 mg/kg), inhalation of sal butamol (1.5 mg), combined treatment, or placebo, the histamine challenge w as repeated. Results: The baseline FEV1 after lidocaine inhalation but prior to the hist amine challenge decreased by > 5% in 7 of 15 volunteers, with a mean (+/- S D) decrease from 3.82 +/- 0.90 to 3.54 +/- 0.86 L (p = 0.0054). The baselin e PC20 for histamine was 6.4 +/- 4.3 mg/mL. Both lidocaine and salbutamol i nhalation significantly increased PC20 more than twofold (14.9 +/- 13.7 and 16.8 +/- 10.9 mg/mL, respectively; p = 0,0007) at a Lidocaine plasma conce ntration of 0.7 +/- 0.3 mu g/mL. Combined treatment quadrupled the PC20 to 29.7 +/- 20.3 mg/mL (vs lidocaine, p = 0.002; vs salbutamol, p = 0.003). Conclusions: Thus, histamine-evoked bronchoconstriction, as a model of refl ex bronchoconstriction, can be significantly attenuated by salbutamol or li docaine inhalation. However, lidocaine inhalation causes significant initia l bronchoconstriction. The combined inhalation of salbutamol and lidocaine prevents the initial bronchoconstriction observed with lidocaine alone and offers even more protection to a histamine challenge than either lidocaine or salbutamol alone. Therefore, the combined inhalation of lidocaine and sa lbutamol can be recommended to mitigate bronchoconstriction when airway ins trumentation is required.